Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin vs Erythromycin for Gastroparesis
NCT01323582Phase 2Terminated
- Sponsor
- University of Florida
- Start
- Feb 2009
- Primary completion
- Dec 2012
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of azithromycin in gastroparesis, sponsored by University of Florida. Primary endpoint: Gastric Emptying Half-Time at 11 weeks. Started Feb 2009; status: terminated.
02
Drugs
azithromycin
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT01323582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01323582.